United States · FDA National Drug Code directory
Fludeoxyglucose F18
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76451-118_47434382-85a5-899c-e063-6294a90ad8d9
- Product NDC
- 76451-118
- Form
- INJECTION
- Composition / generic term
- Fludeoxyglucose F18
- Labeler
- 3D Imaging Drug Design and Development LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120102
- Source listing expiry
- 20271231
Source-listed ingredients
- FLUDEOXYGLUCOSE F-18 — 300 mCi/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 mL in 1 VIAL, GLASS (76451-118-10) · 76451-118-10
- 30 mL in 1 VIAL, GLASS (76451-118-30) · 76451-118-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →